Her-2-neu +: Is growth factor carrying adverse prognosis, but also affords a treatment option, herceptin, (trastuzumab) the her-2-neu + patients get. Triple negative is worse in prognosis than er/pr- , but her-2-neu positive. Being erudite about prognosis does not eliver psycho/emotional comfort. You can survive with poor prognostic signs, and you can proress and die despite all positive factors. Seek peace/accept.
Answered 9/24/2012
5.8k views
Cannot control: I think it's best to play with the cards that you are dealt: if one is her2(-), this usually reflects a less aggressive cancer (although this is only one piece of the puzzle); if one is her2(+), there is a very effective chemotherapeutic agent that can only be used in this setting, herceptin (trastuzumab). Either way, we have many very effective options for breast cancer rx and the odds are in our favor.
Answered 12/31/2014
5.7k views
A doctor has provided 1 answer
7 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question